| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.37 | 0.05 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.33 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.29 | 0.05 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.23 | 0.3 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-08 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |